Arcus Biosciences, Inc.
RCUS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$283,000 | -$307,000 | -$267,000 | $52,830 |
| Dep. & Amort. | $10,000 | $8,000 | $14,000 | $3,843 |
| Deferred Tax | $0 | $0 | $0 | $4,772 |
| Stock-Based Comp. | $76,000 | $73,000 | $0 | $55,000 |
| Change in WC | $22,000 | -$71,000 | $623,000 | -$375,618 |
| Other Non-Cash | $5,000 | -$9,000 | $68,000 | $3,474 |
| Operating Cash Flow | -$170,000 | -$306,000 | $438,000 | -$256,171 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6,000 | -$24,000 | -$6,000 | -$26,078 |
| Net Acquisitions | $0 | $0 | $0 | -$22,000 |
| Inv. Purchases | -$1,043,000 | -$788,000 | -$1,241,000 | -$718,865 |
| Inv. Sales/Matur. | $965,000 | $1,006,000 | $837,000 | $741,075 |
| Other Inv. Act. | $0 | $0 | -$3,000 | $22,000 |
| Investing Cash Flow | -$84,000 | $194,000 | -$413,000 | -$3,868 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $47,000 | $0 | $10,000 | $5,000 |
| Stock Issued | $228,000 | $25,000 | $23,000 | $220,000 |
| Stock Repurch. | $0 | $0 | $0 | -$6 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,000 | $8,000 | $0 | $12,340 |
| Financing Cash Flow | $277,000 | $33,000 | $33,000 | $237,340 |
| Forex Effect | $0 | $0 | $86 | $0 |
| Net Chg. in Cash | $23,000 | -$79,000 | $58,086 | -$22,699 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $130,000 | $209,000 | $147,914 | $173,618 |
| End Cash | $153,000 | $130,000 | $206,000 | $150,919 |
| Free Cash Flow | -$176,000 | -$330,000 | $432,000 | -$282,249 |